Dudnyk bought by Fishawack

Fishawack Group has acquired the rare diseases Philadelphia based healthcare comms agency Dudnyk that offers creative, scientific and strategic capabilities to biotech, medical devices and pharmaceutical clients. President of Dudnyk, Christopher Tobias, said: “Dudnyk brings to Fishawack a particular expertise in rare diseases, oncology, and launching breakthrough molecular medicines. Our seasoned team will complement Fishawack’s already expansive offering, especially in the area of commercial strategy and creative expertise.” 

Dudnyk’s senior leadership team will remain in situ, and CEO of Fishawack Group of Companies, Oliver Dennis, said: “Fishawack has wanted to add an East Coast healthcare marketing agency of scale and is pleased to have found that partnership with Dudnyk. The leadership at Dudnyk clearly cares about their people, their clients, and the rare disease and oncology patients they serve. The organization’s values are very much aligned with ours.

Mr Dennis also said: “Fishawack is unlike traditional networks that make introductions as client needs arise; instead, we form high-performing inter-company business relationships early on. This is important to our clients who depend on continuity of relationships and teams they can depend on. We’re currently undergoing a rebranding of Fishawack that reflects these core beliefs, and we’re looking forward to sharing this with the healthcare marketing community in the near future.”